argenx SE (LON:0QW0)
London · Delayed Price · Currency is GBP · Price in EUR 713.48
+5.87 (0.83%)
At close: Jan 30, 2026
argenx SE Market Cap
argenx SE has a market cap or net worth of 37.3 billion as of January 30, 2026. Its market cap has increased by 16.82% in one year.
Market Cap
37.30B
Enterprise Value
34.43B
Revenue
2.74B
Ranking
n/a
PE Ratio
32.70
Stock Price
713.48
Market Cap Chart
Since July 10, 2014, argenx SE's market cap has increased from 97.26M to 37.30B, an increase of 38,250.38%. That is a compound annual growth rate of 67.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 37.30B | -2.53% |
| Dec 31, 2025 | 38.27B | 27.76% |
| Dec 31, 2024 | 29.95B | 70.09% |
| Dec 29, 2023 | 17.61B | 3.04% |
| Dec 30, 2022 | 17.09B | 24.91% |
| Dec 31, 2021 | 13.68B | 33.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genus | 2.04B |
| Oxford Nanopore Technologies | 1.53B |
| Oxford Biomedica | 1.00B |
| PureTech Health | 319.02M |
| Avacta Group | 231.82M |
| Faron Pharmaceuticals Oy | 195.29M |
| Scancell Holdings | 137.51M |
| Bioventix | 99.27M |